A biosimilar version of the multipurpose biologic drug ustekinumab has been
approved by the FDA and can be swapped interchangeably with the original product sold as Stelara.
The new version carries the brand name Wezlana and the generic name sports the suffix -auub, the FDA said in announcing the approval late…